These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 33434612)

  • 21. Quantitative analysis of diffusion weighted imaging to predict pathological good response to neoadjuvant chemoradiation for locally advanced rectal cancer.
    Tang Z; Zhang XY; Liu Z; Li XT; Shi YJ; Wang S; Fang M; Shen C; Dong E; Sun YS; Tian J
    Radiother Oncol; 2019 Mar; 132():100-108. PubMed ID: 30825957
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MRI T2-weighted sequences-based texture analysis (TA) as a predictor of response to neoadjuvant chemo-radiotherapy (nCRT) in patients with locally advanced rectal cancer (LARC).
    Crimì F; Capelli G; Spolverato G; Bao QR; Florio A; Milite Rossi S; Cecchin D; Albertoni L; Campi C; Pucciarelli S; Stramare R
    Radiol Med; 2020 Dec; 125(12):1216-1224. PubMed ID: 32410063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting the pathologic response of locally advanced rectal cancer to neoadjuvant concurrent chemoradiation using enzyme-linked immunosorbent assays (ELISAs) for biomarkers.
    Yoon HI; Koom WS; Kim YB; Min BS; Lee KY; Kim NK; Shin SJ; Ahn JB; Keum KC
    J Cancer Res Clin Oncol; 2014 Mar; 140(3):399-409. PubMed ID: 24390211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Accuracy of high-resolution rectal magnetic resonance imaging re-staging with histopathology in locally advanced rectal cancer after neoadjuvant chemoradiotherapy.
    Laohawiriyakamol S; Worathanmanon S; Tubtawee T; Kanjanapradit K; Sangkhathat S; Pruphetkaew N; Chongsuvivatwong V
    Asian J Surg; 2021 Jan; 44(1):275-279. PubMed ID: 32712044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Value of Restaging With Chest and Abdominal CT/MRI Scan After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.
    Liu GC; Zhang X; Xie E; An X; Cai PQ; Zhu Y; Tang JH; Kong LH; Lin JZ; Pan ZZ; Ding PR
    Medicine (Baltimore); 2015 Nov; 94(47):e2074. PubMed ID: 26632714
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MR-based artificial intelligence model to assess response to therapy in locally advanced rectal cancer.
    Ferrari R; Mancini-Terracciano C; Voena C; Rengo M; Zerunian M; Ciardiello A; Grasso S; Mare' V; Paramatti R; Russomando A; Santacesaria R; Satta A; Solfaroli Camillocci E; Faccini R; Laghi A
    Eur J Radiol; 2019 Sep; 118():1-9. PubMed ID: 31439226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer.
    Cercek A; Goodman KA; Hajj C; Weisberger E; Segal NH; Reidy-Lagunes DL; Stadler ZK; Wu AJ; Weiser MR; Paty PB; Guillem JG; Nash GM; Temple LK; Garcia-Aguilar J; Saltz LB
    J Natl Compr Canc Netw; 2014 Apr; 12(4):513-9. PubMed ID: 24717570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A Predictive Model to Evaluate Pathologic Complete Response in Rectal Adenocarcinoma.
    Qing S; Gu L; Du T; Yin X; Zhang KJ; Zhang HJ
    Technol Cancer Res Treat; 2023; 22():15330338231202893. PubMed ID: 37750231
    [No Abstract]   [Full Text] [Related]  

  • 29. Does restaging MRI radiomics analysis improve pathological complete response prediction in rectal cancer patients? A prognostic model development.
    Chiloiro G; Cusumano D; de Franco P; Lenkowicz J; Boldrini L; Carano D; Barbaro B; Corvari B; Dinapoli N; Giraffa M; Meldolesi E; Manfredi R; Valentini V; Gambacorta MA
    Radiol Med; 2022 Jan; 127(1):11-20. PubMed ID: 34725772
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Worse prognosis in young patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy: A comparative study.
    Zhang Y; Wang Y; Liu X; Chen B; Zhuang J; Li S; Yang Y; Su Y; Guan G
    Medicine (Baltimore); 2020 Aug; 99(35):e21304. PubMed ID: 32871861
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Accuracy of endoscopic ultrasound in staging and restaging patients with locally advanced rectal cancer undergoing neoadjuvant chemoradiation.
    Marone P; de Bellis M; Avallone A; Delrio P; di Nardo G; D'Angelo V; Tatangelo F; Pecori B; Di Girolamo E; Iaffaioli V; Lastoria S; Battista Rossi G
    Clin Res Hepatol Gastroenterol; 2011 Oct; 35(10):666-70. PubMed ID: 21782549
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer.
    Zhang Y; Yan L; Wu Y; Xu M; Liu X; Guan G
    BMC Cancer; 2020 Sep; 20(1):854. PubMed ID: 32891131
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and validation of a radiopathomics model to predict pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer: a multicentre observational study.
    Feng L; Liu Z; Li C; Li Z; Lou X; Shao L; Wang Y; Huang Y; Chen H; Pang X; Liu S; He F; Zheng J; Meng X; Xie P; Yang G; Ding Y; Wei M; Yun J; Hung MC; Zhou W; Wahl DR; Lan P; Tian J; Wan X
    Lancet Digit Health; 2022 Jan; 4(1):e8-e17. PubMed ID: 34952679
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A prediction model of pathological complete response in patients with locally advanced rectal cancer after PD-1 antibody combined with total neoadjuvant chemoradiotherapy based on MRI radiomics].
    Zhang XY; Zhu HT; Li XT; Li YJ; Li ZW; Wang WH; Wu AW; Sun YS; Zhang L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2022 Mar; 25(3):228-234. PubMed ID: 35340172
    [No Abstract]   [Full Text] [Related]  

  • 35. Apparent Diffusion Coefficient Predicts Pathology Complete Response of Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
    Chen YG; Chen MQ; Guo YY; Li SC; Wu JX; Xu BH
    PLoS One; 2016; 11(4):e0153944. PubMed ID: 27100991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interval between neoadjuvant treatment and definitive surgery in locally advanced rectal cancer: impact on response and oncologic outcomes.
    Calvo FA; Morillo V; Santos M; Serrano J; Gomez-Espí M; Rodriguez M; Del Vale E; Gracia-Sabrido JL; Ferrer C; Sole C
    J Cancer Res Clin Oncol; 2014 Oct; 140(10):1651-60. PubMed ID: 24880919
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.
    Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S
    Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical predictive factors of pathologic complete response in locally advanced rectal cancer.
    De Felice F; Izzo L; Musio D; Magnante AL; Bulzonetti N; Pugliese F; Izzo P; Di Cello P; Lucchetti P; Izzo S; Tombolini V
    Oncotarget; 2016 May; 7(22):33374-80. PubMed ID: 26992214
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Magnetic Resonance, Vendor-independent, Intensity Histogram Analysis Predicting Pathologic Complete Response After Radiochemotherapy of Rectal Cancer.
    Dinapoli N; Barbaro B; Gatta R; Chiloiro G; Casà C; Masciocchi C; Damiani A; Boldrini L; Gambacorta MA; Dezio M; Mattiucci GC; Balducci M; van Soest J; Dekker A; Lambin P; Fiorino C; Sini C; De Cobelli F; Di Muzio N; Gumina C; Passoni P; Manfredi R; Valentini V
    Int J Radiat Oncol Biol Phys; 2018 Nov; 102(4):765-774. PubMed ID: 29891200
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Radiomics Analysis for Evaluation of Pathological Complete Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Liu Z; Zhang XY; Shi YJ; Wang L; Zhu HT; Tang Z; Wang S; Li XT; Tian J; Sun YS
    Clin Cancer Res; 2017 Dec; 23(23):7253-7262. PubMed ID: 28939744
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.